Mandy van Hoek

7.4k total citations · 1 hit paper
45 papers, 1.8k citations indexed

About

Mandy van Hoek is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Mandy van Hoek has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Genetics. Recurrent topics in Mandy van Hoek's work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Diabetes Treatment and Management (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Mandy van Hoek is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Diabetes Treatment and Management (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Mandy van Hoek collaborates with scholars based in Netherlands, Croatia and United Kingdom. Mandy van Hoek's co-authors include Eric J.G. Sijbrands, Abbas Dehghan, Albert Hofman, Jacqueline C.M. Witteman, Cornelia M. van Duijn, Jacqueline C.M. Witteman, Aloysius G. Lieverse, André G. Uitterlinden, Albert Hofman and Thijs T. W. van Herpt and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Mandy van Hoek

44 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes

2008 510 citations Abbas Dehghan, Mandy van Hoek et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mandy van Hoek Netherlands	20	647	443	429	389	376	45	1.8k
Beatriz Fernández‐Fernández Spain	29	850 1.3×	508 1.1×	922 2.1×	307 0.8×	157 0.4×	75	2.7k
Mercedes Muros de Fuentes Spain	13	416 0.6×	402 0.9×	726 1.7×	188 0.5×	175 0.5×	13	1.8k
In Joo Kim South Korea	26	479 0.7×	1.0k 2.3×	515 1.2×	220 0.6×	191 0.5×	136	2.6k
Michele T. Rooney United States	10	538 0.8×	722 1.6×	769 1.8×	248 0.6×	123 0.3×	18	2.1k
Michal Herman‐Edelstein Israel	19	1.1k 1.7×	570 1.3×	950 2.2×	315 0.8×	135 0.4×	33	2.9k
Paul F. Williams Australia	29	622 1.0×	502 1.1×	396 0.9×	282 0.7×	132 0.4×	89	2.6k
Maria Luiza Caramori United States	16	555 0.9×	852 1.9×	1.3k 3.0×	259 0.7×	239 0.6×	32	2.7k
Takuma Narita Japan	26	573 0.9×	661 1.5×	548 1.3×	416 1.1×	95 0.3×	95	2.4k
Thimoteus Speer Germany	27	640 1.0×	374 0.8×	762 1.8×	222 0.6×	108 0.3×	80	2.5k
Monika A. Niewczas United States	31	695 1.1×	842 1.9×	1.9k 4.4×	526 1.4×	421 1.1×	56	3.4k

Countries citing papers authored by Mandy van Hoek

Since Specialization

Citations

This map shows the geographic impact of Mandy van Hoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy van Hoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy van Hoek more than expected).

Fields of papers citing papers by Mandy van Hoek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy van Hoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy van Hoek. The network helps show where Mandy van Hoek may publish in the future.

Co-authorship network of co-authors of Mandy van Hoek

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy van Hoek. A scholar is included among the top collaborators of Mandy van Hoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy van Hoek. Mandy van Hoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rooij, Jeroen van, Mandy van Hoek, Cindy G. Boer, et al.. (2024). Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations. Genome Medicine. 16(1). 10–10. 5 indexed citations

Wagenmakers, Margreet A. E. M., et al.. (2023). Bariatric surgery in a patient with cystic fibrosis and diabetes: A case report. Journal of Cystic Fibrosis. 22(3). 577–579. 3 indexed citations

Nowrouzi‐Sohrabi, Peyman, Reza Tabrizi, Shahla Rezaei, et al.. (2021). Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology. 12. 618208–618208. 8 indexed citations

Zee, Leonie C. van Vark‐van der, Frank Leijten, Mandy van Hoek, et al.. (2021). Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 44. 43–50. 2 indexed citations

Dotz, Viktoria, Bas C. Jansen, Marco R. Bladergroen, et al.. (2021). Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry. Frontiers in Chemistry. 9. 678883–678883. 13 indexed citations

Koromani, Fjorda, Mandy van Hoek, M. Carola Zillikens, et al.. (2021). Type 2 Diabetes Mellitus and Vertebral Fracture Risk. Current Osteoporosis Reports. 19(1). 50–57. 32 indexed citations

Lieverse, Aloysius G., Florian Kronenberg, Claudia Lamina, et al.. (2020). Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus. Diabetologia. 63(6). 1248–1257. 19 indexed citations

Herpt, Thijs T. W. van, et al.. (2020). Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study. Acta Diabetologica. 57(6). 725–732. 15 indexed citations

Dotz, Viktoria, Karli R. Reiding, Agnes L. Hipgrave Ederveen, et al.. (2018). Plasma protein N-glycan signatures of type 2 diabetes. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(12). 2613–2622. 54 indexed citations

10.

Hoek, Mandy van, et al.. (2017). The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review. Journal of clinical lipidology. 11(3). 712–724.e5. 26 indexed citations

11.

Vilaj, Marija, Daniel Urda, Felix Agakov, et al.. (2017). IgG glycan patterns are associated with type 2 diabetes in independent European populations. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(9). 2240–2249. 93 indexed citations

12.

Herpt, Thijs T. W. van, Mandy van Hoek, Janneke G. Langendonk, et al.. (2017). Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes. Diabetology & Metabolic Syndrome. 9(1). 47–47. 18 indexed citations

13.

Vries, Paul S. de, Thijs T. W. van Herpt, Symen Ligthart, et al.. (2016). ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study. Diabetologia. 60(2). 280–286. 17 indexed citations

14.

Herpt, Thijs T. W. van, Abbas Dehghan, Mandy van Hoek, et al.. (2016). The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study. Cardiovascular Diabetology. 15(1). 69–69. 32 indexed citations

15.

Ligthart, Symen, Thijs T. W. van Herpt, Maarten J.G. Leening, et al.. (2015). Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. The Lancet Diabetes & Endocrinology. 4(1). 44–51. 195 indexed citations

16.

Gu, Qian, Mojgan Yazdanpanah, Mandy van Hoek, et al.. (2014). Common variants in PCSK1 influence blood pressure and body mass index. Journal of Human Hypertension. 29(2). 82–86. 6 indexed citations

17.

Hoek, Mandy van, Abbas Dehghan, Albert Hofman, et al.. (2011). Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons. Diabetologia. 54(6). 1360–1367. 18 indexed citations

18.

Mihăescu, Raluca, Mandy van Hoek, Eric J.G. Sijbrands, et al.. (2009). Evaluation of risk prediction updates from commercial genome-wide scans. Genetics in Medicine. 11(8). 588–594. 53 indexed citations

19.

Hoek, Mandy van, Abbas Dehghan, M. Carola Zillikens, et al.. (2008). An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia. 51(8). 1423–1428. 60 indexed citations

20.

Hoek, Mandy van, Leo J. Hofland, Yolanda B. de Rijke, et al.. (2008). Effects of Somatostatin Analogs on a Growth Hormone-Releasing Hormone Secreting Bronchial Carcinoid,in Vivoandin VitroStudies. The Journal of Clinical Endocrinology & Metabolism. 94(2). 428–433. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact